Asthma inhalers are hand-held devices that allow ... Within each class of inhaled asthma medication are different drugs with ...

A collaboration between a drug plan and clinical pharmacists led to nearly 50% of members successfully switching to a preferred dipeptidyl-peptidase-4 inhibitor.

Patients would pay no more than $25 for certain name-brand medications to treat ... to manage chronic illnesses – like needles, inhalers and monitors – was not included in the final compromise ...

BOSTON — Patients would pay no more than $25 for certain name-brand medications to treat ... like needles, inhalers and monitors, was not included in the final compromise, a Friedman aide ...

Costs of brand-name prescriptions have been rising for ... who can now pay only $35 for certain inhalers. And for people with diabetes, following last year’s price cap for insulin for those ...

Patients would pay no more than $25 for certain name-brand medications to treat ... to manage chronic illnesses, like needles, inhalers and monitors, was not included in the final compromise ...

A new year, new breakthroughs! Join us for our annual tradition of compiling and revealing the most interesting things ...

The first-in-class dual phosphodiesterase (PDE) 3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre ... capacity to use regular inhalers. Ohtuvayre is due to ...

The companys name was changed from Glindia Ltd to Glaxo India Ltd. In the year 1990, the production of the bulk drug, cephalexin was commenced at Ankleshwar and the salbutamol inhalers at Nashik.